Close
Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
Show source BACK TO LIST

Laboratory Report

Patient
Name: Hyam, Elizabeth
DOB: 01-SEP-1942 (Age: 83)
Gender: female
Address:
74 Preston Rd
TQ9 3SB Moreleigh (United Kingdom)
ID: 6284-190445-1
Report
Date: 03-AUG-2022
Laboratory
Requested by
Totnes Community Hospital
TQ9 5 Totnes (United Kingdom)
Specimen
Collected: 02-AUG-2022

Chemistry

Test 02 Aug 2022 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.4 4 - 6 %
Glucose [Mass/volume] in Blood 151.3 H 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 17.2 7 - 43 mg/dL
Creatinine [Mass/volume] in Blood 0.5 L 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 9.9 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 143.7 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 5.2 H 3.5 - 5 mmol/L
Chloride [Moles/volume] in Blood 107.9 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 25.8 24 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 242.1 H 239 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 433.9 H 50 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 121.8 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 33.5 L 50 - 100 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 6.4 0 - 30 mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows impaired fasting glucose, hyperlipidemia (elevated total cholesterol and triglycerides, low HDL), and mild hyperkalemia. HbA1c is within target, suggesting no chronic hyperglycemia. Creatinine is slightly low, likely not clinically significant in the elderly. Renal function and microalbuminuria are unremarkable. Recommend further evaluation and management of dyslipidemia and glucose control.